SPYRE THERAPEUTICS, INC.
Lobbying client. Federal LDA filings.
- Source id
69836- General description
- Biotechnology company focused on treatments for gastrointestinal and rheumatic diseases.
- State
- MA
- Country
- US
- Principal place of business
- US
- Effective date
- 2025-11-07
- Total spend (across 1 ingested filings)
- $40,000
Filings (1) — $40,000
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-04-20 | Q1 | 2026 | ARNOLD & PORTER KAYE SCHOLER LLP | $40,000 |
Connected on the graph
2 typed relationships in the influence graph — 2 inbound, 0 outbound, grouped by type.
lobbied for (2)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| — | ← | Bobby Mcmillin | — | lda_lobbyist_client | |
| — | ← | Luke Albert | — | lda_lobbyist_client |